Table 2.
TCOAD (N=202) | PLACEBO (N=204) | P VALUE | |
---|---|---|---|
DURATION OF CURRENT EPISODE (MONTHS) | |||
Mean (SD) | 14.3 (38.0) | 15.0 (22.2) | 0.55 |
PREVIOUS EPISODES IN THE LAST 24 MONTHS | |||
Mean number of previous episodes in the last 24 months2 | |||
n | 166 | 173 | |
Mean (SD) | 1.0 (0.9) | 1.1 (1.2) | 0.40 |
Number of patients with previous episodes in the last 24 months2 | |||
n | 166 | 173 | |
Patients with 0 episode | 54 (32.5%) | 53 (30.6%) | 0.80 |
Patients with 1 episode | 67 (40.4%) | 76 (43.9%) | |
Patients with 2 episodes | 36 (21.7%) | 35 (20.2%) | |
Patients with 3 episodes or more | 9 (5.4%) | 9 (5.2%) |
P values were calculated using Fisher's exact test for categorical variables and ANOVA with pooled site and treatment as categorical factors for continuous variables.
Data were based on the total number of patients with complete records; 31 patients had missing records in the placebo group and 36 patients had missing records in the active treatment group.
TCOAD=Trazodone Contramid OAD